ProfileGDS5678 / 1439685_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 52% 52% 52% 50% 53% 53% 50% 52% 52% 55% 52% 51% 51% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3107952
GSM967853U87-EV human glioblastoma xenograft - Control 23.2731952
GSM967854U87-EV human glioblastoma xenograft - Control 33.2741952
GSM967855U87-EV human glioblastoma xenograft - Control 43.1552650
GSM967856U87-EV human glioblastoma xenograft - Control 53.2662153
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3998253
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2781950
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2727752
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2485252
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3685855
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2689352
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2055151
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2345151
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2719452